AGM/EGMApr 28, 2026, 04:14 PM
FENC Sets Annual Meeting for June 10, 2026; Proposes Equity Plan Increase
AI Summary
Fennec Pharmaceuticals Inc. announced its Annual Meeting of Shareholders will be held virtually on June 10, 2026. Shareholders will vote on setting the board size at five and electing five directors, noting the departure of Mr. Rostislav Raykov. Other proposals include the appointment of auditors, advisory votes on executive compensation and its frequency, and approving an increase in shares reserved for the 2020 Equity Incentive Plan to 10,000,000, along with adopting a new 2026 Equity Inducement Plan.
Key Highlights
- Annual Meeting of Shareholders scheduled for June 10, 2026, at 10:00 a.m. EDT.
- Board of directors size to be set at five, with five directors to be elected.
- Rostislav Raykov will not be standing for re-election as a director.
- Proposes increasing shares reserved for 2020 Equity Incentive Plan to 10,000,000 Common Shares.
- Proposes adopting a new 2026 Equity Inducement Plan.
- Haskell & White LLP proposed for re-appointment as auditors for the year ending December 31, 2026.
- Advisory vote on executive compensation and frequency of future advisory votes (board recommends every 1 year).
- 34,712,756 Common Shares outstanding as of April 13, 2026.
Price Impact
More from FENC